Healthcare
Univec, Inc.(UNVC)
Live Price
Offline$0.0014
-6.67% today
1Y Change
-44.00%
Window
Jun 23, 2025 → Jun 11, 2026
- Market Cap
- $10.00M
- Revenue Growth
- +131.0%
- EPS Growth
- +200.0%
- Dividend Yield
- 0.0%
Coverage: 245 bars · Jun 23, 2025 → Jun 11, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Univec, Inc. (UNVC) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.00 and down 44.0% across the available one-year price window (Jun 23, 2025 → Jun 11, 2026). Baseline metrics include revenue growth of +131.0%, EPS growth of +200.0%, a dividend yield of 0.0%. What stands out right now is revenue +131.0%, EPS +200.0%, free cash flow -28175.0% with operating margin -1495.6% and ROIC 7.8%. Valuation already assumes a fairly strong business story at price/sales 59.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines UNVC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+131.0% vs +7.6% peer median
Operating Margin
Below sector median
-1495.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +131.0% and EPS at +200.0%, with operating margin around -1495.6%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UNVC
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UNVC Max Drawdown
-70.21%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for UNVC and SPY.
Company Overview
Univec, Inc.
Other OTC
Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.
- Leadership
- David Dalton
- IPO Date
- Apr 24, 1997
- Employees
- 3
- Street Address
- 822 Guilford Avenue
- Mailing
- Owings Mills, MD, 21202
- Region
- Owings Mills, MD, US
- Reporting Currency
- USD
- Investor Line
- 410-347-9959
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 59.4
- Price/Book
- —
Growth
- Revenue
- +131.0%
- EPS
- +200.0%
- Free Cash Flow
- -28175.0%
Profitability
- Gross Margin
- 11.2%
- Operating Margin
- -1495.6%
- Net Margin
- -1429.6%
- ROE
- 7.1%
- ROIC
- 7.8%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.